Amarin Corp Plc (AMRN)

[couldbebetter]

The JELIS study shows EPA has beneficial results in humans. The question is how much a benefit will Reduce-It show. Anything at 15% or higher and AMRN should be golden. Given that our study has very sick people in it I think if Vascepa is effective it will show in the results...especially when you consider the very high dose of EPA used. My guess as to why this dosage is that it is better to overtreat rather than undertreat. As safe as EPA is at these strong dosages you will have some initial side effects as the body adjusts to the strong dosae. I think JL stated that patients should not start at the full dose but work their way up to it over the course of a month. 4 grams EPA is very powerful. The JELIS study only used 1.8 grams. That alone is a huge difference. Again, I think AMRN is going for the best possible reults here...i do hope it works out that way.